Prosecution Insights
Last updated: April 19, 2026

Floratek Pharma S A

4 pending office actions

Portfolio Summary

4
Total Pending OAs
0
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18288743 NOVEL HETEROCYCLIC COMPOUNDS SAEED, KAMAL A 1626 Non-Final OA Oct 27, 2023
18275850 HETEROAROMATIC SPERMIDINE ANALOGUES AND THEIR ANTICANCER ACTIVITY SCHMIDT, IZABELA MARIA 1621 Non-Final OA Aug 04, 2023
18275847 FLAVONE DEAZA SPERMIDINE ANALOGUES AND THEIR USE TREATING CANCER FERGUSON, JALISA HOLMES 1626 Non-Final OA Aug 04, 2023
18274314 HETEROAROMATIC PHOSPHONIUM SALTS AND THEIR USE TREATING CANCER HOWELL, THEODORE R 1628 Non-Final OA Jul 26, 2023

Managing Floratek Pharma S A's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month